Articles

How Is Thoracic Cancer Diagnosed? Imaging, PET-CT & Biopsy | Dr Sanjay Sharma

Thoracic cancer refers to cancers that develop in the chest, including cancers of the lungs, pleura, mediastinum, chest wall and other structures within the thoracic cavity. Lung cancer is one of the most common thoracic cancers, but diagnosing thoracic cancer is not as simple as performing a single scan or blood test. Doctors generally combine a patient's symptoms, medical history, physical examination, imaging tests and, when required, tissue or fluid sampling to determine whether cancer is present and understand its type and extent.

For patients experiencing persistent cough, unexplained breathlessness, chest discomfort, coughing up blood, unexplained weight loss or an abnormality detected on a chest scan, timely evaluation by an experienced cancer specialist is important. A Thoracic oncologist in Mumbai or thoracic surgeon in Bandra can help determine which diagnostic tests are appropriate and whether a suspicious finding requires further investigation.

For patients looking for a cancer doctor in Cumballa Hospital, understanding the diagnostic journey can make the process less confusing. From the initial chest X-ray and CT scan to PET-CT, bronchoscopy and biopsy, each test provides a different piece of information that helps doctors develop an accurate diagnosis and treatment plan.

What Is Thoracic Cancer?

Thoracic cancer is a broad term used for cancers occurring within the chest. Lung cancer is the most commonly recognised thoracic malignancy, but thoracic cancers can also involve the pleura, mediastinum, chest wall and other structures.

The diagnostic approach depends on where the abnormality is located, its size and appearance, whether lymph nodes are involved, whether there is fluid around the lungs and whether there are signs that the disease has spread elsewhere in the body.

Importantly, an abnormality on an X-ray or CT scan does not automatically mean cancer. Lung nodules and masses can also occur because of infections, inflammation, scarring and other non-cancerous conditions. This is why imaging findings often need to be interpreted alongside the patient's history and, when indicated, tissue examination.

When Should You See a Thoracic Cancer Specialist?

Thoracic cancer can sometimes develop without obvious symptoms, particularly during its early stages. However, certain symptoms should not be ignored, especially if they persist or worsen.

A persistent or unexplained cough, coughing up blood, recurrent chest infections, unexplained weight loss, persistent chest pain, shortness of breath, unexplained fatigue, hoarseness or changes in breathing may require medical evaluation.

People with a significant history of smoking or exposure to certain occupational or environmental risk factors may also require a more careful assessment based on their individual risk profile.

If an abnormality has already been identified on a chest X-ray or CT scan, consulting a thoracic oncologist in Mumbai or an experienced cancer surgeon in Bandra can help determine the next appropriate step rather than assuming that every lung nodule requires immediate surgery.

Step 1: Medical History and Clinical Examination

The diagnostic process usually begins with a detailed discussion between the patient and doctor.

The doctor may ask about the duration and nature of symptoms, smoking history, previous cancers, occupational exposures, family history, previous infections and other relevant medical conditions. A physical examination may also be performed.

This initial assessment helps the doctor decide whether imaging or additional investigations are necessary.

There is no single test that can diagnose every cancer. Depending on the clinical situation, doctors may use laboratory tests, imaging and biopsy procedures to establish the diagnosis.

For this reason, patients searching for the best cancer specialist in Cumballa Hospital should look for a specialist who can evaluate the complete diagnostic picture rather than interpreting an isolated scan report.

Step 2: Chest X-Ray — Often the First Imaging Test

A chest X-ray is frequently one of the first investigations performed when a patient presents with respiratory symptoms..

It can identify certain abnormalities in the lungs and chest, including masses, areas of infection, fluid around the lungs or other changes. However, a normal or inconclusive X-ray does not necessarily exclude cancer.

If the X-ray shows something suspicious, or if symptoms continue despite an apparently normal X-ray, the doctor may recommend more detailed imaging, particularly a CT scan.

This is one reason why persistent symptoms should not simply be ignored because an initial chest X-ray appears reassuring.

Step 3: CT Scan — A More Detailed Look at the Chest

A CT scan provides much more detailed cross-sectional images than a conventional chest X-ray. It can help doctors assess the size, shape and location of a lung lesion and examine surrounding structures and lymph nodes.

CT imaging may help identify whether a suspicious finding is a small pulmonary nodule, larger mass or abnormal lymph node. It can also provide important information about the relationship between a tumour and nearby blood vessels, airways and other structures.

In some cases, contrast material may be used to improve visualisation of particular structures.

CT imaging can also play an important role in planning a biopsy because it can help doctors precisely locate an abnormal area.

For a patient being evaluated by a thoracic surgeon in Bandra, CT findings may therefore influence whether the next step should involve surveillance, additional imaging, bronchoscopy, needle biopsy or another procedure.

Step 4: PET-CT — Looking Beyond the Primary Tumour

When cancer is suspected or confirmed, a PET-CT may be recommended in selected patients.

A PET scan provides information about metabolic activity within tissues, while CT provides detailed anatomical images. When combined, PET-CT can help doctors identify areas of increased activity and understand where disease may be located.

PET-CT is particularly useful in evaluating the extent of disease and assisting with cancer staging. It may also help identify an appropriate area for biopsy in certain situations.

However, increased uptake on a PET scan does not automatically prove that an area is cancerous. Infection and inflammation can also cause increased metabolic activity. Therefore, PET-CT findings need to be interpreted within the patient's complete clinical context.

Step 5: MRI When Specific Areas Need Closer Evaluation

MRI is not routinely required for every suspected thoracic cancer, but it can be useful when doctors need detailed information about particular soft-tissue structures or possible spread to areas such as the brain or other sites.

The decision to perform an MRI depends on the suspected cancer type, symptoms, stage and findings from other investigations.

A personalised approach is important because not every patient requires every available scan.

Step 6: Bronchoscopy — Looking Inside the Airways

If an abnormality is located within or close to the airways, bronchoscopy may be recommended.

During bronchoscopy, a thin tube with a camera is passed through the nose or mouth into the windpipe and airways. This allows the doctor to directly examine the respiratory passages and, when necessary, obtain samples from suspicious areas.

Bronchoscopy can also be used to investigate symptoms such as persistent cough, coughing up blood, unexplained breathlessness or an abnormality detected on imaging.

Because tissue can sometimes be collected during the same procedure, bronchoscopy can be an important part of the diagnostic pathway for selected lung cancers.

Step 7: EBUS — Evaluating Lymph Nodes Inside the Chest

Endobronchial ultrasound, commonly called EBUS, combines bronchoscopy with ultrasound imaging.

It allows doctors to visualise lymph nodes and structures located around the airways and can help guide a needle to obtain tissue samples.

This can be particularly useful when doctors need to determine whether cancer has spread to lymph nodes within the chest. Accurate lymph-node assessment can influence the stage of cancer and subsequently affect treatment planning.

EBUS is therefore an important minimally invasive diagnostic and staging technique in modern lung cancer care.

Step 8: CT-Guided Needle Biopsy

Not every lung tumour can be reached effectively through the airways. When a suspicious lesion is located toward the outer portion of the lung, a CT-guided transthoracic needle biopsy may be considered.

During this procedure, imaging is used to guide a needle through the chest wall toward the abnormal area so that a tissue sample can be obtained.

The sample is then sent to a pathology laboratory for examination.

The advantage of image-guided biopsy is that it can provide tissue without requiring a major surgical procedure. However, as with any medical procedure, the doctor needs to consider the location of the lesion, the patient's health and the potential risks before recommending it.

Step 9: Why Is a Biopsy So Important?

One of the most important questions patients ask is: “Can a CT scan confirm lung cancer?”

In most cases, imaging can show that an abnormality is suspicious, but imaging alone usually cannot provide the definitive microscopic diagnosis.

A biopsy allows a pathologist to examine cells or tissue under a microscope. This helps determine whether cancer is present and, when cancer is identified, what type of cancer it is.

This distinction is extremely important because different types and subtypes of thoracic cancers can require very different treatments.

Therefore, an experienced cancer specialist in Cumballa Hospital will generally consider not just “whether there is a tumour,” but also what the tumour is biologically and how it behaves.

Step 10: Pathology — Identifying the Type of Cancer

Once a biopsy has been obtained, the tissue is examined by a pathologist.

The pathology report may identify whether the tumour represents a particular type of lung cancer or another cancer involving the thorax.

For example, lung cancers may broadly include non-small cell lung cancer and small cell lung cancer, with further subtypes within these categories.

Correct classification matters because treatment decisions can depend on the exact diagnosis.

Sometimes additional laboratory tests are performed on the biopsy sample to provide more information about the tumour.

Step 11: Molecular Testing and Biomarker Testing

Modern lung cancer diagnosis has moved beyond simply identifying cancer under a microscope.

For certain patients, particularly those with non-small cell lung cancer, molecular testing may identify specific genetic alterations that can influence treatment selection. Biomarker testing such as PD-L1 testing may also help determine whether particular systemic therapies, including immunotherapy, could be appropriate.

Liquid biopsy, which analyses tumour-related DNA circulating in the bloodstream, may also be considered in selected situations, particularly when obtaining adequate tissue is difficult or unsafe.

This is one of the major changes in modern thoracic oncology: diagnosis and treatment planning are increasingly connected.

The goal is not simply to determine “Is this cancer?” but also to understand what kind of cancer it is and which treatments may be most appropriate.

Does Every Lung Nodule Need a Biopsy?

No.

A lung nodule does not automatically mean lung cancer, and not every nodule requires immediate biopsy.

Doctors consider several factors, including the size, shape, location and appearance of the nodule, as well as the patient's age, medical history and risk factors.

Some nodules may be monitored with follow-up imaging, while others may require PET imaging or tissue sampling. If a nodule grows or has concerning characteristics, additional evaluation may become necessary.

This is why an individualised assessment by a thoracic oncologist in Mumbai is important.

How Doctors Decide Which Biopsy Is Best?

There is no single biopsy method that is ideal for every patient.

The location of the tumour is one of the most important factors. A lesion located near a major airway may be accessible through bronchoscopy. A peripheral lung lesion may be more suitable for CT-guided needle biopsy. Enlarged lymph nodes in the chest may sometimes be sampled using EBUS.

In selected situations where less invasive procedures cannot provide sufficient tissue, a surgical approach may be considered.

The objective is to obtain an adequate and safe tissue sample while minimising unnecessary procedures.

What Happens After Thoracic Cancer Is Confirmed?

Diagnosis is only the beginning.

Once cancer is confirmed, doctors need to determine its stage. Staging evaluates the size and location of the primary tumour, lymph-node involvement and whether cancer has spread to distant organs.

This information helps the multidisciplinary cancer team determine whether treatment should involve surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy or a combination of treatments.

For patients who may be candidates for surgery, lung function testing can also be important because it helps doctors assess whether the patient's lungs can tolerate the planned operation.

This is where consultation with an experienced cancer surgeon in Bandra or thoracic surgeon in Bandra can become particularly valuable.

Why Early and Accurate Diagnosis Matters?

Thoracic cancer diagnosis is not simply about finding a tumour. It is about understanding the tumour accurately enough to make the right treatment decisions.

An incorrect assumption based only on symptoms or a scan can potentially delay appropriate care. Conversely, unnecessary invasive procedures may be avoided when imaging and clinical findings suggest that monitoring is more appropriate.

A structured diagnostic pathway from clinical evaluation and imaging to biopsy, pathology, molecular testing and staging helps create a more complete picture of the disease.

For patients in Mumbai, seeking evaluation from an experienced specialist can help ensure that suspicious chest findings are assessed systematically and that treatment discussions begin with accurate information.

Looking for a Thoracic Cancer Specialist in Bandra or Cumballa Hospital?

If you or a family member has been diagnosed with a lung mass, pulmonary nodule, suspected thoracic cancer or an abnormal chest scan, timely specialist evaluation can help clarify what the findings mean and what should happen next.

Dr. Sanjay Sharma provides specialist cancer care for patients requiring evaluation and treatment of thoracic and other cancers in Mumbai. Patients looking for a thoracic oncologist in Mumbai, thoracic surgeon in Bandra, cancer surgeon in Bandra, or a cancer doctor in Cumballa Hospital can seek an individualised assessment based on their symptoms, imaging findings, biopsy results and overall health.

The right diagnostic pathway depends on the individual patient. A suspicious scan does not always mean cancer, and a confirmed diagnosis does not mean every patient requires the same treatment. With appropriate imaging, biopsy, pathology and staging, doctors can develop a treatment approach based on the specific cancer and the patient's needs.

If you have an abnormal chest scan, persistent respiratory symptoms or a suspected lung tumour, consult a qualified cancer specialist rather than delaying evaluation or interpreting the scan on your own.